SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001840315-24-000002
Filing Date
2024-01-16
Accepted
2024-01-16 18:55:01
Documents
1
Period of Report
2024-01-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3156
  Complete submission text file 0001840315-24-000002.txt   5206
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 56F, ONE MUSEUM PLACE 669 XIN ZHA ROAD JING'AN DISTRICT, SHANGHAI F4 200041
Business Address 56F, ONE MUSEUM PLACE 669 XIN ZHA ROAD JING'AN DISTRICT, SHANGHAI F4 200041 862122893688
Ocumension Therapeutics (Reporting) CIK: 0001840315 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 24536391